Nitric oxide production in meningococcal disease is directly related to disease severity

Critical Care Medicine

Volumn 27, Issue 6, 1999, Pages 1187-1190

  Baines, Paul B ^a   Stanford, Salome ^b   Bishop Bailey, David ^b   Sills, John A ^a   Thomson, Alistair P J ^a   Mitchell, Jane A ^c   Fear, Simon C ^d   Hart, C Anthony ^e   Petros, Andy J ^c  

^a ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Critical illness; Meningococcal; Neisseria meningitidis; Nitric oxide; Pediatrics; Sepsis

Indexed keywords

NITRIC OXIDE;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CRITICAL ILLNESS; DISEASE SEVERITY; HUMAN; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; SCORING SYSTEM;

CHILD; GLASGOW COMA SCALE; HUMANS; INTENSIVE CARE UNITS, PEDIATRIC; MENINGOCOCCAL INFECTIONS; NITRATES; NITRIC OXIDE; NITRITES; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 0033010456     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199906000-00050     Document Type: Article

References (16)

1. 1. Thomson APJ, Hart CA, Sills JA: Meningococcal disease in Liverpool children 1977-1987: Mode of presentation. Paediatr Rev Communications 1991; 5:109-116
2. 2. Thomson APJ, Sills JA, Hart CA: Validation of the Glasgow meningococcal septicemic prognostic score: A ten year retrospective survey. Crit Care Med 1991; 19:26-30
3. 3. Marzouk O: Clinical and laboratory aspects of meningococcal disease in children. Doctoral Thesis. Liverpool, University of Liverpool, 1994
4. 4. Waage A, Halstensen A, Espevik T: Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987; i:355-357
5. 5. Riordan FAI, Marzouk O, Thomson APJ, et al: Proinflammatory and anti-inflammatory cytokines in meningococcal disease. Arch Dis Child 1996; 75:453-454
6. 6. Angaard E: Nitric oxide: Mediator, murderer, and medicine. Lancet 1994; 343:1199-1206
7. 7. Brady AJB, Warren JB, Poole-Wilson PA, et al: Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 1993; 265: H176-H182
8. 8. Wong HR, Carcillo JA, Burckart G, et al: Nitric oxide production in critically ill patients. Arch Dis Child 1996; 74:482-489
9. 9. The Meningococcal Disease Surveillance Group: Meningococcal disease, secondary attack rate and chemoprophylaxis in the United States, 1974. JAMA 1976; 235:261-265
10. 10. Pollack MM, Ruttiman UE: Pediatric risk of mortality (PRISM) score. Crit Care Med 1988; 16:1110-1116
11. 11. Sinclair JF, Skeoch CH, Hallworth D: Prognosis of meningococcal septicaemia. Lancet 1987; ii:38
12. 12. Schmidt HHHW, Warner TD, Nakane M, et al: Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. Mol Pharmacol 1992; 41: 615-624
13. 13. Kennedy NJ, Duncan AW: Acute meningococcaemia: Recent advances in management (with particular reference to children). Anaesth Intensive Care 1996; 24:197-216
14. 14. Brandtzaeg P, Kierulf P, Gaustad P, et al: Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 1989; 159: 195-204
15. 15. Cobb JP, Cunnion RE, Danner RL: Nitric oxide as a target for therapy in septic shock. Crit Care Med 1993; 21:1261-1263
16. 16. Liu SF, Adcock IM, Old RW, et al: Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment in vivo in the rat. Crit Care Med 1996; 24:1219-1225